Impaired vibrotactile sense at low frequencies in fingers in autoantibody positive and negative diabetes

Diabetes Research and Clinical Practice

Volumn 100, Issue 2, 2013, Pages

  Dahlin, E ^a   Ekholm, E ^a   Gottsater A ^a   Speidel, T ^b   Dahlin, L B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b PID AB   (Sweden)

Author keywords

Autoantibody; Diabetes; Finger pulps; Meissner's corpuscles; Vibrotactile sense

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; PANCREAS ISLET CELL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; HUMAN; IMPAIRED VIBROTACTILE SENSE; INDEX FINGER; MALE; MECHANORECEPTOR; NERVE FIBER; PERCEPTIVE THRESHOLD; SENSORY DYSFUNCTION; VIBRATION;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; FINGERS; HUMANS; MALE; MIDDLE AGED; VIBRATION;

EID: 84878356181     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.01.026     Document Type: Article

References (16)

1. Kamiya H., Murakawa Y., Zhang W., Sima A.A. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diabetes Metab Res Rev 2005, 21:448-458.
2. Sima A.A., Kamiya H. Diabetic neuropathy differs in type 1 and type 2 diabetes. Ann N Y Acad Sci 2006, 1084:235-249.
3. Dahlin L.B., Thrainsdottir S., Cederlund R., Thomsen N.O., Eriksson K.F., Rosen I., et al. Vibrotactile sense in median and ulnar nerve innervated fingers of men with Type 2 diabetes, normal or impaired glucose tolerance. Diabet Med 2008, 25:543-549.
4. Dahlin L.B., Granberg V., Rolandsson O., Rosen I., Dahlin E., Sundkvist G. Disturbed vibrotactile sense in finger pulps in patients with Type 1 diabetes - correlations with glycaemic level, clinical examination and electrophysiology. Diabet Med 2011, 28:1045-1052.
5. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 1993, 43:817-824.
6. Ziegler D., Muhlen H., Gries F.A. Neurophysiological tests in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients with subclinical and symptomatic neuropathy. Diabetologia 1992, 35:1099-1100.
7. Ekholm E., Gottsater A., Dahlin L.B., Sundkvist G. No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetol 2011, 49(1):57-62.
8. Stromberg T., Dahlin L.B., Lundborg G. Vibrotactile sense in the hand-arm vibration syndrome. Scand J Work Environ Health 1998, 24:495-502.
9. Gardner E.P., Martin J.H., Jessell T.M. Coding of sensory information. Principles of Neural Science 2000, 411-429. McGraw-Hill, New York. E.R. Kandel, J.H. Schwartz, T.M. Jessell (Eds.).
10. Gottsater A., Landin-Olsson M., Lernmark A., Fernlund P., Sundkvist G. Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients. Acta Diabetol 1994, 31:226-231.
11. Gottsater A., Ahmed M., Lilja B., Fernlund P., Sundkvist G. Islet cell antibodies at diagnosis, but not leanness, relate to a better cardiovascular risk factor profile 5 years after diagnosis of NIDDM. Diabetes Care 1996, 19:60-63.
12. Gottsater A., Ryden-Ahlgren A., Szelag B., Hedblad B., Persson J., Berglund G., et al. Cardiovascular autonomic neuropathy associated with carotid atherosclerosis in Type 2 diabetic patients. Diabet Med 2003, 20:495-499.
13. Khan M.W., Banga K., Mashal S.N., Khan W.A. Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications. BMC Immunol 2011, 12:19.
14. Jensen R.A., Agardh E., Lernmark A., Gudbjornsdottir S., Smith N.L., Siscovick D.S., et al. HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later. PLoS One 2011, 6:e17569.
15. Zimering M.B., Alder J., Pan Z., Donnelly R.J. Anti-endothelial and anti-neuronal effects from auto-antibodies in subsets of adult diabetes having a cluster of microvascular complications. Diabetes Res Clin Pract 2011, 93:95-105.
16. Tesfaye S., Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?. Curr Diab Rep 2009, 9:432-434.